We Build Bridges in Rare Diseases

We are called Strongbridge for a reason. We're building a strong clinical and financial foundation to connect patients with new treatments for rare diseases.

Focus. Commitment. Passion. That’s Strongbridge.

Agile Clinical Development

Strongbridge is committed to bridging treatment gaps as rapidly as possible. We are building rare disease franchises that aim to utilize accelerated regulatory pathways when possible.

Strongbridge Leadership Team

The Strongbridge leadership team exemplifies the company’s approach—rare focus, rare commitment, and rare passion.

Our People Are Our Foundation

Strongbridge is looking for smart, driven people to join our growing and dynamic team. Learn more at the Strongbridge Careers page.
Strongbridge Financial Information

We are building a strong financial foundation to enable clinical innovation

© 2019 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
Macrilen™ is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V14 08/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
[email protected]

Privacy Statement
Compliance Program